Back to Search Start Over

The drp-1-mediated mitochondrial fission inhibitor mdivi-1 impacts the function of ion channels and pathways underpinning vascular smooth muscle tone.

Authors :
Ahmed, Amer
Trezza, Alfonso
Gentile, Mariangela
Paccagnini, Eugenio
Lupetti, Pietro
Spiga, Ottavia
Bova, Sergio
Fusi, Fabio
Source :
Biochemical Pharmacology. Sep2022, Vol. 203, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

[Display omitted] Mdivi-1 is widely used as a pharmacological tool to inhibit dynamin-related protein-1-mediated mitochondrial fission. Whether this compound may interact directly or indirectly with ion channels or cellular pathways fundamental for the regulation of vascular smooth muscle tone remains unknown. The present study aimed to assess the effect of mdivi-1 on Ca V 1.2 and K Ca 1.1 channels, both in vitro and in silico as well as on the mechanical activity of rat aorta rings. Mdivi-1 was an effective Ca V 1.2 channel blocker, docking in a Ca V 1.2 channel antagonist binding region, stimulated K Ca 1.1 channel current, binding to a sensing region common to other stimulators, and possibly inhibited the Rho-kinase pathway. These effects contributed to its vasorelaxant activity observed in rings stimulated with high KCl, phenylephrine, or NaF. Neither structurally different dynamin inhibitors nor a stimulator affected the Ca2+ antagonistic and vasorelaxant activities of the compound. However, mito-tempol reduced its vasorelaxant potency towards phenylephrine. Finally, mdivi-1 antagonized mitochondrial fission triggered by phenylephrine. In conclusion, mdivi-1 is an effective in vitro vasorelaxant agent at concentrations routinely employed to block dynamin-related protein-1. Ion channels and pathways key to the maintenance of vessel active tone are involved in this mechanism. These yet undiscovered off-target effects raise caution for the interpretation of mitochondrial fission signalling. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00062952
Volume :
203
Database :
Academic Search Index
Journal :
Biochemical Pharmacology
Publication Type :
Academic Journal
Accession number :
158607527
Full Text :
https://doi.org/10.1016/j.bcp.2022.115205